Skip to content

Improving medication safety for patients with chronic renal impairment in general practice

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN02900734
Enrollment
400
Registered
2007-05-30
Start date
2007-02-21
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic renal impairment (grade III or higher) Urological and Genital Diseases Renal impairment

Interventions

Each participating practice attended one of four consecutive introductory meetings and was randomised to the intervention or control group. The practices are told to recruit ten suitable patients duri

Sponsors

German Federal Ministry of Education and Research (Bundesministerium Für Bildung und Forschung [BMBF]) (Germany)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient level: 1. Patients with established chronic renal impaiment grade III or higher (creatinine clearance below 50 ml/min) 2. Patients at risk of developing chronic renal impairment (70 years or older with hypertension = risk group) Practice level: 1. Use of computer during consultation 2. Use of computer for prescribing medications

Exclusion criteria

Exclusion criteria: Patient level: 1. Terminally ill patients 2. Patients with dialysis treatment Practice level: Routine use of an electronic support system for dose adaption in patients with chronic renal impairment.

Design outcomes

Primary

MeasureTime frame
Number of medications which have not been correctly adjusted to patient's renal function, measured at baseline (T0) and again after six months (T1).

Secondary

MeasureTime frame
1. Number of patients in risk group with recently measured creatinine, measured at baseline (T0) and again after six months (T1) 2. Assessment of feasibility and usefulness of the tested electronic support system by participating General Practices (GP's), measured at baseline (T0) and again after six months (T1)

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 25, 2026